ITMCTR2200005834
Recruiting
Phase 1
A multicenter, randomized, controlled clinical trial of efficacy and safety of xinan Guben Peiyuan formula series in the treatment of COPD
The First Affiliated Hospital of Anhui University of Chinese Medicine0 sitesTBD
ConditionsChronic obstructive pulmonary disease
Overview
- Phase
- Phase 1
- Intervention
- Not specified
- Conditions
- Chronic obstructive pulmonary disease
- Sponsor
- The First Affiliated Hospital of Anhui University of Chinese Medicine
- Status
- Recruiting
- Last Updated
- 3 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •? Patients who meet the diagnostic criteria for COPD; ? It belongs to stable period; ? It conforms to the TCM syndrome differentiation standard of lung qi deficiency/Lung spleen qi deficiency/lung kidney qi deficiency; ?40 years \= age \=75 years; ? Did not participate in other clinical studies 3 month before enrollment; ? No antibiotics were used 3 month before enrollment; ? Voluntarily accept treatment, sign informed consent before the test, and fully understand the content, process and possible adverse reactions of the test.
Exclusion Criteria
- •If the answer to any of the following questions is yes, the patient will not be admitted to the study: ? Allergic constitution or allergic to the known ingredients of the test drug or control drug; ? Extremely severe COPD patients and acute stage patients; ? Pregnant and lactation women; ? Delirious, dementia, all kinds of mental patients; ? Functional grade ? and hemodynamic instability; ? With bronchiectasis, bronchial asthma, active pulmonary tuberculosis, pulmonary embolism, pneumothorax, pleural effusion, malignant tumor and other neuromuscular diseases affecting respiratory motor function;? Severe liver and kidney disease (severe liver disease refers to cirrhosis, portal hypertension and varicose bleeding, serious kidney disease including dialysis, kidney transplantation); ? all kinds of reasons for long\-term bed. ? Persons who have participated in other interventional clinical trials within the last 3 months; ? Participants considered unsuitable for the clinical trial by the investigator.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Phase 1
A multicenter, randomized, controlled clinical trial of Hydroxychloroquine or new Tripterygium compound in the treatment of IgA nephropathyIgA nephropathyITMCTR2100004723Peking University First Hospital
Active, not recruiting
Not Applicable
A randomized, controlled, multicenter clinical trial comparing the efficacy of Peginterferon alfa-2a and ribavirin and metformin versus Peginterferon alfa-2a and ribavirin for the treatment of naïve patients with chronic hepatitis C (CHC) and insulin resistance. - NDCHRONIC ACTIVE HEPATITIS C ASSOCIATED WITH INSULIN RESISTANCEMedDRA version: 6.1Level: PTClassification code 10019744EUCTR2005-003853-29-ITAZIENDA SANITARIA OSPEDALIERA S. GIOVANNI BATTISTA DI TORINO
Recruiting
Not Applicable
Effectiveness of Bi-Sai-Tong solution for moderate to severe allergic rhinitis: a randomized controlled studyITMCTR1900002527Guangdong Provincial Hospital of Chinese Medicine
Active, not recruiting
Not Applicable
Study comparing the use of a medical procedure (endoscopic band ligation) versus a drug treatment (carvedilol) to prevent bleeding of esophageal varices in patients with liver disease.Esophageal variceal bleeding in patients with cirrhosisTherapeutic area: Diseases [C] - Digestive System Diseases [C06]EUCTR2011-006208-11-ESCAIBER
Active, not recruiting
Phase 1
Study to compare the clinical and radiological efficacy of 625 mg vs 1250 mg of oral methylprednisolone in patients with multiple sclerosis in relapse.Multiple sclerosisMedDRA version: 15.0Level: PTClassification code 10028245Term: Multiple sclerosisSystem Organ Class: 10029205 - Nervous system disordersTherapeutic area: Diseases [C] - Nervous System Diseases [C10]EUCTR2012-001965-34-ESServicio de Neurología, HU. Germans Trias i Pujol